diazooxonorleucine and Carcinoma, Non-Small Cell Lung

diazooxonorleucine has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Belinsky, SA; Chen, W; Do, KC; Filipczak, P; Leng, S; Lin, Y; Saxton, B; Tessema, M1

Other Studies

1 other study(ies) available for diazooxonorleucine and Carcinoma, Non-Small Cell Lung

ArticleYear
Inhibition of the hexosamine biosynthesis pathway potentiates cisplatin cytotoxicity by decreasing BiP expression in non-small-cell lung cancer cells.
    Molecular carcinogenesis, 2019, Volume: 58, Issue:6

    Topics: A549 Cells; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Diazooxonorleucine; Down-Regulation; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Gene Expression Regulation, Neoplastic; Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing); Heat-Shock Proteins; Hexosamines; Humans; Lung Neoplasms

2019